Skip to main content
Premium Trial:

Request an Annual Quote

Policy Changes Needed to Prevent Disparities in Genetically Based Medicine

NEW YORK (GenomeWeb) – Despite the promise of genetically based diagnoses and treatments, ensuring that disadvantaged groups can benefit from such medical advances will require a number of changes in healthcare and research policies, according to a new report published this week.

"Unprecedented advances in genetically based diagnoses and treatments provide opportunities for personalized medicine," Tufts University researcher Jose Ordovas and his colleagues wrote in Health Affairs. "However, disadvantaged groups may lack access to these advances, and treatments based on research on non-Hispanic whites might not be generalizable to members of minority groups. Unless genetic technologies become universally accessible, existing disparities could be widened."

In the paper, the team — which included scientists from the University of Washington, the University of Illinois at Chicago, Ohio State University, Johns Hopkins University, the University of North Carolina at Chapel Hill, the University of Massachusetts, and the Black Hills Center for American Indian Health — focused on breast cancer and chronic kidney disease to highlight the existence of racial and ethnic disparities in healthcare.

To address the problem, the researchers recommended expanding genetic research to include more non-white participants, as well as efforts to promote participation in community-based research to help improve genetic literacy. They also called for increased funding to support efforts studying the interplay between genetics and the environment, and enhancing access to genetic technologies for minority populations in ways that avoid stigmatization.

"We need to collect more data from groups for whom we currently have insufficient information so that we can improve care for all individuals," Ordovas said in a statement. "Increasing diversity in research and testing will help maximize the possibilities of precision medicine."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.